PBYI · Insider Trading
PUMA BIOTECHNOLOGY INC
Every open-market purchase and sale reported by PBYI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-16 | Troy Edward Wilson | Director | Sell | −5,000 | −$45.50K |
| 2026-09-16 | Alessandra Cesano | Director | MIXED | −12,150 | −$420.49K |
| 2026-07-08 | Douglas M Hunt | See Remarks | Sell | −8,460 | −$69.90K |
| 2026-07-08 | Maximo F Nougues | Chief Financial Officer | Sell | −9,386 | −$77.56K |
| 2026-07-08 | Alan H Auerbach | President and CEO | Sell | −44,058 | −$364.05K |
| 2026-06-15 | Alessandra Cesano | Director | A | +27,000 | — |
| 2026-06-15 | Jay M Moyes | Director | MIXED | +5,000 | −$158.80K |
| 2026-06-15 | Adrian Senderowicz | Director | MIXED | — | −$194.31K |
| 2026-06-15 | Allison Dorval | Director | MIXED | +15,390 | −$83.58K |
| 2026-06-15 | Michael Patrick Miller | Director | A | +27,000 | — |
| 2026-06-15 | Troy Edward Wilson | Director | MIXED | +16,200 | −$77.75K |
| 2026-06-15 | Brian M Stuglik | Director | MIXED | +18,900 | −$58.31K |
| 2026-02-20 | Douglas M Hunt | See Remarks | A | +49,394 | — |
| 2026-02-20 | Alan H Auerbach | President and CEO | A | +159,778 | — |
| 2026-02-20 | Maximo F Nougues | Chief Financial Officer | A | +46,739 | — |
| 2026-01-08 | Douglas M Hunt | See Remarks | Sell | −8,987 | −$52.70K |
| 2026-01-08 | Maximo F Nougues | Chief Financial Officer | Sell | −10,945 | −$64.19K |
| 2026-01-08 | Alan H Auerbach | President and CEO | Sell | −34,950 | −$204.88K |
| 2025-11-13 | Michael Patrick Miller | Director | Sell | −20,000 | −$97.23K |
| 2025-07-22 | Alessandra Cesano | Director | Sell | −27,000 | −$90.91K |
| 2025-07-10 | Douglas M Hunt | See Remarks | Sell | −7,817 | −$27.62K |
| 2025-07-10 | Alan H Auerbach | President and CEO | Sell | −47,172 | −$166.70K |
| 2025-07-10 | Maximo F Nougues | Chief Financial Officer | Sell | −9,522 | −$33.65K |
| 2025-06-17 | Brian M Stuglik | Director | Sell | −8,100 | −$27.46K |
| 2025-06-17 | Allison Dorval | Director | Sell | −11,610 | −$39.47K |
| 2025-06-17 | Jay M Moyes | Director | Sell | −22,000 | −$74.80K |
| 2025-06-17 | Adrian Senderowicz | Director | Sell | −27,000 | −$91.80K |
| 2025-06-17 | Alessandra Cesano | Director | Sell | −12,150 | −$41.31K |
| 2025-06-17 | Troy Edward Wilson | Director | Sell | −10,800 | −$36.72K |
| 2025-06-13 | Brian M Stuglik | Director | A | +27,000 | — |
| 2025-06-13 | Michael Patrick Miller | Director | A | +27,000 | — |
| 2025-06-13 | Jay M Moyes | Director | A | +27,000 | — |
| 2025-06-13 | Alessandra Cesano | Director | A | +27,000 | — |
| 2025-06-13 | Allison Dorval | Director | A | +27,000 | — |
| 2025-06-13 | Adrian Senderowicz | Director | A | +27,000 | — |
| 2025-06-13 | Troy Edward Wilson | Director | A | +27,000 | — |
| 2025-02-11 | Maximo F Nougues | Chief Financial Officer | A | +61,456 | — |
| 2025-02-11 | Alan H Auerbach | President and CEO | A | +198,399 | — |
| 2025-02-11 | Douglas M Hunt | See Remarks | A | +48,117 | — |
| 2025-02-11 | Jeffrey Jerome Ludwig | Chief Commercial Officer | A | +47,841 | — |
| 2025-01-03 | Alan H Auerbach | President and CEO | Sell | −33,841 | −$106.66K |
| 2025-01-03 | Jeffrey Jerome Ludwig | Chief Commercial Officer | Sell | −9,437 | −$29.74K |
| 2025-01-03 | Douglas M Hunt | See Remarks | Sell | −8,633 | −$27.21K |
| 2025-01-03 | Maximo F Nougues | Chief Financial Officer | Sell | −10,227 | −$32.23K |
| 2024-08-13 | Michael Patrick Miller | Director | Sell | −23,358 | −$81.47K |
| 2024-07-18 | Douglas M Hunt | See Remarks | Sell | −3,637 | −$13.46K |
| 2024-07-18 | Jeffrey Jerome Ludwig | Chief Commercial Officer | Sell | −2,598 | −$9.62K |
| 2024-07-18 | Maximo F Nougues | Chief Financial Officer | Sell | −4,156 | −$15.38K |
| 2024-07-18 | Alan H Auerbach | President and CEO | Sell | −21,920 | −$81.13K |
| 2024-07-02 | Alan H Auerbach | President and CEO | Sell | −18,885 | −$61.73K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Alan H Auerbach | President and CEO | 7,261,671 | $76.10M |
| Maximo F Nougues | Chief Financial Officer | 230,637 | $2.42M |
| Douglas M Hunt | See Remarks | 196,841 | $2.06M |
| Jeffrey Jerome Ludwig | Chief Commercial Officer | 156,792 | $1.64M |
| Brian M Stuglik | Director | 121,958 | $1.28M |
| Allison Dorval | Director | 102,390 | $1.07M |
| Michael Patrick Miller | Director | 81,000 | $848.88K |
| Jay M Moyes | Director | 58,322 | $611.21K |
| Alessandra Cesano | Director | 56,700 | $594.22K |
| Troy Edward Wilson | Director | 55,150 | $577.97K |
| Adrian Senderowicz | Director | 27,000 | $282.96K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the PBYI quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.